Stay updated on Cabometyx + Avelumab in mRCC Clinical Trial

Sign up to get notified when there's something new on the Cabometyx + Avelumab in mRCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabometyx + Avelumab in mRCC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The clinical trial record for cabozantinib and avelumab in metastatic renal cell carcinoma is displayed, including its study design, eligibility requirements, treatment details, and outcomes. The record also provides investigator, publication, and study-date information.
    Difference
    45%
    Check dated 2026-11-07T14:03:52.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.2 to v3.8.0; the page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-31T14:45:19.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T19:14:51.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T20:12:54.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The displayed site revision changed from v3.7.0 to v3.7.1. The study record still shows a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T20:31:03.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with the standard header and footer, indicating access to the study record is blocked. This reflects a permission/availability issue rather than an update to substantive study content.
    Difference
    18%
    Check dated 2026-09-19T20:20:45.000Z thumbnail image

Stay in the know with updates to Cabometyx + Avelumab in mRCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabometyx + Avelumab in mRCC Clinical Trial page.